Document Detail

Midodrine improves ejaculation in spinal cord injured men.
MedLine Citation:
PMID:  17869290     Owner:  NLM     Status:  MEDLINE    
PURPOSE: We evaluated the effect of the alpha1-adrenergic agonist midodrine given orally for anejaculation in spinal cord injured men. MATERIALS AND METHODS: A total of 185 spinal cord injured patients who reported absent ejaculation during sexual intercourse and who failed to respond to penile vibratory stimulation were treated with midodrine 30 to 120 minutes before a new stimulation. The procedure was repeated weekly, increasing doses by 7.5 mg to a maximum of 30 mg. Cardiovascular effects were monitored throughout the procedure. RESULTS: Antegrade or retrograde ejaculation was achieved in 102 spinal cord injured men (64.6%). A positive response was more frequent in patients with complete lesions (American Spinal Injury Association A) and upper motor neuron lesions above T10. Midodrine induced a significant but moderate increase (maximum 10 mm Hg) in mean arterial pressure in all patients. The highest systolic blood pressure (more than 200 mm Hg) was seen in patients with quadriplegia. No other significant side effect was recorded. The average dose of midodrine required for ejaculation was 18.7 mg. CONCLUSIONS: Midodrine is a safe and efficient adjunct to penile vibratory stimulation for anejaculation in spinal cord injured patients.
J M Soler; J G Previnaire; P Plante; P Denys; E Chartier-Kastler
Publication Detail:
Type:  Journal Article     Date:  2007-09-17
Journal Detail:
Title:  The Journal of urology     Volume:  178     ISSN:  0022-5347     ISO Abbreviation:  J. Urol.     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-10-15     Completed Date:  2007-11-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2082-6     Citation Subset:  AIM; IM    
Laboratoire d'urodynamique et de sexologie, Centre Bouffard Vercelli, Cap Peyrefite, Cerbère, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Adrenergic alpha-Agonists / administration & dosage,  therapeutic use*
Coitus / physiology
Dose-Response Relationship, Drug
Ejaculation / drug effects*
Erectile Dysfunction / drug therapy*,  etiology,  physiopathology
Follow-Up Studies
Midodrine / administration & dosage,  therapeutic use*
Retrospective Studies
Spinal Cord Injuries / complications*,  physiopathology
Thoracic Vertebrae
Treatment Outcome
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 42794-76-3/Midodrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ideal culture time for improvement in sperm motility from testicular sperm aspirates of men with azo...
Next Document:  Responsiveness and minimum important differences for the erection quality scale.